Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors

Prakash Thangavel,1 Buddolla Viswanath,1 Sanghyo Kim1,2 1Department of Bionanotechnology, Gachon University, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, 2Graduate Gachon Medical Research Institute, Gil Medical Center, Incheon, Republic of Korea Abstract: In recent years, the field of meta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thangavel P, Viswanath B, Kim S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/1495aff1f628420cbf4d5c96df76d1f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1495aff1f628420cbf4d5c96df76d1f3
record_format dspace
spelling oai:doaj.org-article:1495aff1f628420cbf4d5c96df76d1f32021-12-02T02:53:19ZRecent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors1178-2013https://doaj.org/article/1495aff1f628420cbf4d5c96df76d1f32017-04-01T00:00:00Zhttps://www.dovepress.com/recent-developments-in-the-nanostructured-materials-functionalized-wit-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Prakash Thangavel,1 Buddolla Viswanath,1 Sanghyo Kim1,2 1Department of Bionanotechnology, Gachon University, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, 2Graduate Gachon Medical Research Institute, Gil Medical Center, Incheon, Republic of Korea Abstract: In recent years, the field of metal-based drugs has been dominated by other existing precious metal drugs, and many researchers have focused their attention on the synthesis of various ruthenium (Ru) complexes due to their potential medical and pharmaceutical applications. The beneficial properties of Ru, which make it a highly promising therapeutic agent, include its variable oxidation states, low toxicity, high selectivity for diseased cells, ligand exchange properties, and the ability to mimic iron binding to biomolecules. In addition, Ru complexes have favorable adsorption properties, along with excellent photochemical and photophysical properties, which make them promising tools for photodynamic therapy. At present, nanostructured materials functionalized with Ru complexes have become an efficient way to administer Ru-based anticancer drugs for cancer treatment. In this review, the recent developments in the nanostructured materials functionalized with Ru complexes for targeted drug delivery to tumors are discussed. In addition, information on “traditional” (ie, non-nanostructured) Ru-based cancer therapies is included in a precise manner. Keywords: metallodrugs, nanotechnology, cancer treatment, cell apoptosis, DNA damage, toxicityThangavel PViswanath BKim SDove Medical PressarticleRuthenium complexessynthesisnanostructured materialscytotoxic effecttargeted deliveryMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 2749-2758 (2017)
institution DOAJ
collection DOAJ
language EN
topic Ruthenium complexes
synthesis
nanostructured materials
cytotoxic effect
targeted delivery
Medicine (General)
R5-920
spellingShingle Ruthenium complexes
synthesis
nanostructured materials
cytotoxic effect
targeted delivery
Medicine (General)
R5-920
Thangavel P
Viswanath B
Kim S
Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
description Prakash Thangavel,1 Buddolla Viswanath,1 Sanghyo Kim1,2 1Department of Bionanotechnology, Gachon University, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, 2Graduate Gachon Medical Research Institute, Gil Medical Center, Incheon, Republic of Korea Abstract: In recent years, the field of metal-based drugs has been dominated by other existing precious metal drugs, and many researchers have focused their attention on the synthesis of various ruthenium (Ru) complexes due to their potential medical and pharmaceutical applications. The beneficial properties of Ru, which make it a highly promising therapeutic agent, include its variable oxidation states, low toxicity, high selectivity for diseased cells, ligand exchange properties, and the ability to mimic iron binding to biomolecules. In addition, Ru complexes have favorable adsorption properties, along with excellent photochemical and photophysical properties, which make them promising tools for photodynamic therapy. At present, nanostructured materials functionalized with Ru complexes have become an efficient way to administer Ru-based anticancer drugs for cancer treatment. In this review, the recent developments in the nanostructured materials functionalized with Ru complexes for targeted drug delivery to tumors are discussed. In addition, information on “traditional” (ie, non-nanostructured) Ru-based cancer therapies is included in a precise manner. Keywords: metallodrugs, nanotechnology, cancer treatment, cell apoptosis, DNA damage, toxicity
format article
author Thangavel P
Viswanath B
Kim S
author_facet Thangavel P
Viswanath B
Kim S
author_sort Thangavel P
title Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
title_short Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
title_full Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
title_fullStr Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
title_full_unstemmed Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
title_sort recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/1495aff1f628420cbf4d5c96df76d1f3
work_keys_str_mv AT thangavelp recentdevelopmentsinthenanostructuredmaterialsfunctionalizedwithrutheniumcomplexesfortargeteddrugdeliverytotumors
AT viswanathb recentdevelopmentsinthenanostructuredmaterialsfunctionalizedwithrutheniumcomplexesfortargeteddrugdeliverytotumors
AT kims recentdevelopmentsinthenanostructuredmaterialsfunctionalizedwithrutheniumcomplexesfortargeteddrugdeliverytotumors
_version_ 1718402023783661568